As KLC2 is a cargo protein that transports proteins involved in cell signaling [15,18], we hypothesized that KLC2-MT would deregulate CML cell growth and apoptosis by modulating STAT3 activation and subcellular localization. This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.